In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, RAPT Therapeutics Inc (NASDAQ: RAPT) closed at $0.82 down -2.75% from its previous closing price of $0.84. In other words, the price has decreased by -$2.75 from its previous closing price. On the day, 0.58 million shares were traded. RAPT stock price reached its highest trading level at $0.93 during the session, while it also had its lowest trading level at $0.8126.
Ratios:
For a deeper understanding of RAPT Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.90 and its Current Ratio is at 9.90. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on November 13, 2024, Downgraded its rating to Hold and sets its target price to $2 from $7 previously.
On November 11, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $8 to $2.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 05 ’24 when Brockstedt Dirk G. sold 898 shares for $22.78 per share. The transaction valued at 20,456 led to the insider holds 27,820 shares of the business.
HO WILLIAM sold 2,500 shares of RAPT for $54,200 on Dec 21 ’23. The Chief Medical Officer now owns 15,020 shares after completing the transaction at $21.68 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RAPT now has a Market Capitalization of 28595890 and an Enterprise Value of -64189148.
Stock Price History:
Over the past 52 weeks, RAPT has reached a high of $27.35, while it has fallen to a 52-week low of $0.84. The 50-Day Moving Average of the stock is -47.52%, while the 200-Day Moving Average is calculated to be -78.51%.
Shares Statistics:
For the past three months, RAPT has traded an average of 544.11K shares per day and 334900 over the past ten days. A total of 34.90M shares are outstanding, with a floating share count of 30.57M. Insiders hold about 12.56% of the company’s shares, while institutions hold 75.05% stake in the company. Shares short for RAPT as of 1732838400 were 1373341 with a Short Ratio of 2.52, compared to 1730332800 on 2668533. Therefore, it implies a Short% of Shares Outstanding of 1373341 and a Short% of Float of 5.2800003.
